Clinical Topics & News

Oral Therapies for Psoriasis: Report From the AAD Meeting

From the Icahn School of Medicine at Mount Sinai, New York, New York.


 

Patients with psoriasis now have several treatment options to help control their disease. Among them are oral therapies. Dr. Gary Goldenberg reviews clearance data on approved therapies and ones on the horizon.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Brodalumab approval recommended, despite possible suicide signal
Psoriasis Collection
Psoriatic arthritis patients have elevated risk for coronary artery plaque
Psoriasis Collection
Psoriasiform eruptions in Kawasaki disease reveal distinct phenotype
Psoriasis Collection
Benefits, challenges emerge in evolution of rheumatology-dermatology clinics
Psoriasis Collection
Weight loss boosts TNFi’s psoriatic arthritis efficacy
Psoriasis Collection
Psoriatic arthritis patients face more endocrine comorbidities
Psoriasis Collection
Psoriatic flare assessment tool in validation stage
Psoriasis Collection
Ultrasound’s role in detecting enthesitis in psoriatic arthritis remains debatable
Psoriasis Collection
Skin microbiome may differ in unique ways in psoriatic arthritis, psoriasis patients
Psoriasis Collection
Shining a light on nonplaque psoriasis
Psoriasis Collection